SRE Holdings Corporation

Business Details

Operating along two axes—Life & Healthcare Solutions (LH) and PropTech Solutions (PT)—this segment provides operations-support cloud tools and DX solutions to customers in the healthcare, finance, and real estate domains. The source of competitive advantage is the "real business × AI growth eco-cycle," in which proprietary data accumulated through the company's own real business operations is fed back into AI training. The accumulation of ARR and low churn rates have expanded recurring revenue, achieving the highest operating margin within the group.

Recent Overview

Achieved 15.5% revenue growth and 41.0% operating profit growth driven by strengthened data infrastructure in the healthcare domain and the effect of PT price revisions

In FY2026 (ending March 2026), AICC's external customer revenue was ¥6,507 million (up 15.5% year-on-year), and segment profit was ¥3,475 million (up 41.0% year-on-year), representing a substantial profit increase. In the healthcare domain, the grouping of operating companies and the acquisition of related operations strengthened the on-site operational data and billing-related data infrastructure, improving the quality and quantity of AI training data. The number of contracted companies in the LH domain increased steadily, and operating margin improved through more efficient support operations. In the PT domain, the effect of price revisions contributed throughout the full year, and recurring revenue accumulated. Note that an impairment loss of ¥579 million was recorded as an extraordinary loss in connection with a review of a subsidiary's role.

Key Products

Growth Drivers

• Sustained high demand for cross-industry AX/DX driven by the shortage of specialized personnel amid a declining working-age population
• Continued strengthening of entry barriers through the "real business × AI growth eco-cycle," in which proprietary data accumulated through the company's own real business is fed back into AI training
• Further expansion of the on-site data infrastructure in the healthcare domain through the grouping of operating companies and acquisition of related operations
• Improved operating margin in the LH domain due to steady growth in the number of contracted companies and more efficient support operations
• Expanded cross-selling through the full-year contribution of price revision effects in the PT domain and strengthened positioning as an AX/DX partner
• Establishment of a framework for acquiring operational data for both senior residences and medical/nursing care through partnerships with Sony Financial Group and others
• Establishment of a rigorous feedback loop and increased switching costs through the group's paid internal provision model
• Expansion of the addressable customer range through the full-scale rollout of support for major customers in the healthcare domain (outlook for FY2027, ending March 2027)

Risks

• Risk of increased response costs due to regulatory changes (institutional reforms in the healthcare and finance domains)
• Risk of loss of customer trust due to data security incidents
• Risk of relative decline in the competitive advantage of industry-specific AI due to the rapid evolution of general-purpose generative AI
• Risk of impairment of goodwill arising from M&A (balance of ¥2,700 million at the end of FY2026, ending March 2026)
• Risk of rising costs related to securing and retaining skilled specialized personnel
• Risk of additional impairment associated with a review of the roles of subsidiaries and related assets (an impairment of ¥579 million was recorded in the current period)